Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy.
Burman
W J
WJ
Denver Public Health and the Department of Medicine (Division of Infectious Diseases), University of Colorado Health Sciences Center, Denver, Colorado, USA. bburman@dhha.org
Jones
B E
BE
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000995:Antitubercular Agents / Q000009:adverse effects / Q000493:pharmacokinetics; D000998:Antiviral Agents / Q000009:adverse effects / Q000493:pharmacokinetics; D018791:CD4 Lymphocyte Count; D004347:Drug Interactions; D006801:Humans; D019338:Polypharmacy; D011480:Protease Inhibitors / Q000009:adverse effects / Q000493:pharmacokinetics; D014376:Tuberculosis / Q000188:drug therapy*
D000995:Antitubercular Agents; D000998:Antiviral Agents; D011480:Protease Inhibitors